Search
for

    Glossary Norgestimate

    synthetic progestin used in hormonal contraceptives

    Norgestimate is a synthetic progestin commonly used in combination with estrogen in hormonal contraceptives. It works by mimicking the hormone progesterone, helping to regulate ovulation and menstrual cycles, and is often chosen for its relatively low androgenic activity, which can reduce side effects like acne and hair loss.

    Sort by

    Research 30 of 150

    1. Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i> Gynecological Endocrinology · 2000 · 78 citations
    2. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis The European Journal of Contraception & Reproductive Health Care · 2012 · 63 citations
    3. The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders ˜The œAmerican journal of medicine · 1995 · 57 citations
    4. Combined hormonal contraception and venous thromboembolism The European Journal of Contraception & Reproductive Health Care · 2007 · 46 citations
    5. Endocrinological evaluation and hormonal therapy for women with difficult acne Journal of The European Academy of Dermatology and Venereology · 2001 · 30 citations
    6. Androgenic effects of oral contraceptives: Implications for patient compliance The American Journal of Medicine · 1995 · 22 citations
    7. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data BJOG: An International Journal of Obstetrics and Gynaecology · 2022 · 3 citations
    8. The acne hormones John Wiley & Sons, Ltd eBooks · 2014
    9. Dienogest Drugs · 1998 · 64 citations
    10. The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study American Journal of Clinical Dermatology · 2018 · 22 citations
    11. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature International Journal of Women's Health · 2014 · 16 citations
    12. The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified? The European Journal of Contraception & Reproductive Health Care · 2013 · 1 citations
    13. Treatment of Hair Loss The New England Journal of Medicine · 1999 · 370 citations
    14. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocrine Reviews · 2008 · 343 citations
    15. Acne The New England Journal of Medicine · 2005 · 231 citations
    16. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial The Lancet HIV · 2015 · 210 citations
    17. Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials The Journal of Clinical Endocrinology & Metabolism · 2008 · 121 citations
    18. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review American Journal of Clinical Dermatology · 2017 · 117 citations
    19. Hormonal Therapy for Acne Seminars in Cutaneous Medicine and Surgery · 2008 · 96 citations
    20. Polycystic Ovary Syndrome: Update on Diagnosis and Treatment The American Journal of Medicine · 2014 · 92 citations
    21. Polycystic Ovarian Syndrome Medical Clinics of North America · 2014 · 89 citations
    22. ??-Hydroxy Acid???Based Cosmetic Procedures American Journal of Clinical Dermatology · 2000 · 87 citations
    23. Hair Loss in Women Seminars in Cutaneous Medicine and Surgery · 2009 · 81 citations
    24. Hormonal therapy for acne: why not as first line therapy? facts and controversies Clinics in Dermatology · 2009 · 76 citations
    25. Dermatologic Manifestations of Polycystic Ovary Syndrome American Journal of Clinical Dermatology · 2007 · 76 citations
    26. MENSTRUAL DISORDERS IN ADOLESCENTS Pediatric Clinics of North America · 1999 · 75 citations
    27. Dermatology of androgen-related disorders Clinics in Dermatology · 2006 · 67 citations
    28. Menopause and aging, quality of life and sexuality Climacteric · 2007 · 55 citations
    29. Selected Disorders of Skin Appendages—Acne, Alopecia, Hyperhidrosis Medical Clinics of North America · 2015 · 51 citations
    30. Sulfatase inhibitors: a patent review Expert Opinion on Therapeutic Patents · 2012 · 47 citations